Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

• Principais autores: G. Adami (Autor), L. Idolazzi (Autor), C. Benini (Autor), E. Fracassi (Autor), A. Carletto (Autor), O. Viapiana (Autor), D. Gatti (Autor), M. Rossini (Autor), A. Fassio (Autor)
• Formato: Livro
• Publicado em: PAGEPress Publications, 2023-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Psoriatic arthritis (PsA) is an inflammatory disease characterized by peripheral and axial involvement. Biological disease-modifying antirheumatic drugs (bDMARDs) are the mainstream treatment for PsA and bDMARDs retention rate is a proxy for the drug's overall effectiveness. However, it is uncl...